BridgeMD
New treatment option for Hip Fracture
Official title PENG Block: Continuous Infusion vs. Programmed Intermittent Bolus in Neck of Femur Fracture
ClinicalTrials.gov ID: NCT07046052
What this study is testing
- What it's testing
- Pericapsular Nerve Group Block (PENG) is an effective regional anaesthesia modality in providing analgesia following neck of femur fracture. Continuous PENG techniques, using indwelling catheters and infusions of local anaesthetic, facilitate the continuation of analgesia for a number of days following hip fracture surgery.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- English-speaking
- over the age of 18 years
- hemiarthroplasty for fractured neck of femur
- able to provide written consent.
You likely can't join if
- under 50kg body weight.
- unable to provide consent due to incapacity
- pregnant women
- vulnerable adults under state guardianship
- Patients with pre-existing chronic pain disorders or with a history of long-term opioid use
- those with contraindications to a peripheral nerve block such as local site infection, allergy to local anaesthetic or those who are coagulopathic
The study team makes the final eligibility decision.
Where it's taking place
- Cork, Cork, Ireland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cork, Cork, Ireland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.